GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Forza Innovations Inc (OTCPK:FORZ) » Definitions » Risk Assessment

Forza Innovations (Forza Innovations) Risk Assessment


View and export this data going back to 2017. Start your Free Trial

What is Forza Innovations Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Forza Innovations is: No Data: Cannot be evaluated.

Competitive Comparison of Forza Innovations's Risk Assessment

For the Medical Devices subindustry, Forza Innovations's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forza Innovations's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Forza Innovations's Risk Assessment falls into.


Forza Innovations  (OTCPK:FORZ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Forza Innovations Risk Assessment Related Terms

Thank you for viewing the detailed overview of Forza Innovations's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Forza Innovations (Forza Innovations) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Forza Innovations Inc (OTCPK:FORZ) » Definitions » Risk Assessment
Comparable Companies
USAQ EMED RTSL VRAYQ NNMX INBS RSLS NUMD NUWE ESMC ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
406 9th Avenue, Suite 210, San Diego, CA, USA, 92101
Website
https://forzinnovations.com
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.
Executives
Johnny Forzani director, 10 percent owner, officer: Pres., CEO, Sec., Treas., CFO 30 FORZANI WAY, CALGARY A0 T3Z 1L5
Shefali Vibhakar director, 10 percent owner, officer: President, CEO, CFO, Sec. Trea 1914 24TH AVE E, PALMETTO FL 34221
Tom Forzani director 30 FORZANI WAY, CALGARY A0 T3Z 1L5
Geoff Stanbury director BOX 25 SITE 1 RR1, MILLARVILLE A0 T0L 1K0